Global Dextrose and Sodium Chloride Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dextrose and Sodium Chloride Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Glucose Sodium Chloride Injection is a compound preparation, corresponding to different contents of glucose and sodium chloride according to the specification. It is used to supplement heat energy and body fluids, as well as lack of food or loss of a large amount of body fluids caused by various reasons. Its side effects can cause hypernatremia and hypokalemia, and can cause bicarbonate loss.
Dextrose and Sodium Chloride Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dextrose and Sodium Chloride Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dextrose and Sodium Chloride Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Dextrose and Sodium Chloride Injection key manufacturers include Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., China Resources Double-crane Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., Anhui Fengyuan Pharmaceutical Co.,Ltd. and Cisen Pharmaceutical, etc. Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd. are top 3 players and held % sales share in total in 2022.
Dextrose and Sodium Chloride Injection can be divided into 100ml, 250ml, 500ml and Other, etc. 100ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Dextrose and Sodium Chloride Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Dextrose and Sodium Chloride Injection industry development. In 2022, global % sales of Dextrose and Sodium Chloride Injection went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dextrose and Sodium Chloride Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Specifications, Application and Regions Listed in the Report
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Segment by Specifications
100ml
250ml
500ml
Other
Hospitals
Clinics
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dextrose and Sodium Chloride Injection market further
Chapter 1Product Definition, Product Specificationss, Volume and Revenue analysis of Each Specifications in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dextrose and Sodium Chloride Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dextrose and Sodium Chloride Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dextrose and Sodium Chloride Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dextrose and Sodium Chloride Injection introduction, etc. Dextrose and Sodium Chloride Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dextrose and Sodium Chloride Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Dextrose and Sodium Chloride Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dextrose and Sodium Chloride Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Dextrose and Sodium Chloride Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Dextrose and Sodium Chloride Injection key manufacturers include Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., China Resources Double-crane Pharmaceutical Co.,Ltd., Sichuan Biokin Pharmaceutical Co.,Ltd., Anhui Fengyuan Pharmaceutical Co.,Ltd. and Cisen Pharmaceutical, etc. Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd. are top 3 players and held % sales share in total in 2022.
Dextrose and Sodium Chloride Injection can be divided into 100ml, 250ml, 500ml and Other, etc. 100ml is the mainstream product in the market, accounting for % sales share globally in 2022.
Dextrose and Sodium Chloride Injection is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Dextrose and Sodium Chloride Injection industry development. In 2022, global % sales of Dextrose and Sodium Chloride Injection went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dextrose and Sodium Chloride Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Specifications, Application and Regions Listed in the Report
By Company
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Segment by Specifications
100ml
250ml
500ml
Other
Segment by Application
Hospitals
Clinics
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dextrose and Sodium Chloride Injection market further
Chapter 1Product Definition, Product Specificationss, Volume and Revenue analysis of Each Specifications in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Dextrose and Sodium Chloride Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Dextrose and Sodium Chloride Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Dextrose and Sodium Chloride Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Dextrose and Sodium Chloride Injection introduction, etc. Dextrose and Sodium Chloride Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Dextrose and Sodium Chloride Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices